ARTICLE | Company News
Akzo Nobel NV, sanofi-aventis sales and marketing update
December 12, 2005 8:00 AM UTC
AKZ's Organon USA Inc. unit (Roseland, N.J.) received rights to promote SAN's Anzemet dolasetron to anesthesiologists. The serotonin (5-HT3) antagonist is approved to treat and prevent post-operative ...